EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Willingness to Participate in Deprescribing Trials: A Survey of Older Adults in Two Countries

Sarah E Vordenberg iD, Noelia Dulo, Alexander Chaitoff iD, Kirsten Ingwersen, Kristie Rebecca Weir iD

Journal of the American Geriatrics Society · 2026

DOI: 10.1111/jgs.70186 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Geriatrics Society, 2026. Verfasst von Sarah E Vordenberg und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, Michigan, USA. Hauptthemen laut MEDLINE: Deprescriptions, Patient Participation, Clinical Trials as Topic. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, University of Michigan Center for Bioethics and Social Sciences in Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study investigates the willingness of older adults to participate in a hypothetical deprescribing clinical trial.

Methods

We conducted an online survey of adults aged 65+ years in Australia and the United States. Participants rated their willingness to enroll in a deprescribing trial, responding to the statement, “Research is conducted to assess the safety and effectiveness of stopping medicines. Imagine your doctor made you aware of a research trial aiming to help people stop one or more of their medicines. To what extent would you be willing to enroll in the study?” on a 6‐point Likert scale with “Not at all willing (1)” and “Extremely willing (6)” as the scale anchors. Participants provided a brief free‐text explanation. We dichotomized the outcome variable as willing (scores 4–6) and unwilling (scores 1–3) to enroll and conducted descriptive analyses, chi‐square tests, and univariate and multivariate logistic regression models. Free‐text responses were analyzed using content analysis, with descriptive statistics summarizing themes.

Results

There were 2334 participants in the quantitative analysis and 2237 participants in the content analysis. Most were willing ( n = 1705, 73%) rather than unwilling ( n = 629, 27%) to enroll in a deprescribing trial ( p < 0.001, 95% CI 0.712, 0.748). Over one‐half of participants ( n = 1252, 56%) expressed the “positive about deprescribing trials” domain, with Australian participants more likely to do so ( AU 666 [60%] vs. US 586 [52%], p < 0.001).

Participants

( n = 1047, 47%) frequently reported at least one theme of the “concerns and hesitations” domain ( n = 669, 30%) with US participants more frequently expressing negative views ( US 273 [24%] vs. AU 211 [19%], p = 0.002) and reporting the “mistrust” theme ( US 74 [7%] vs. AU 35 [3%], p < 0.001).

Conclusions

Older adults showed a willingness to engage in deprescribing trials, though concerns may affect enrollment. Clear communication of risks and benefits could support recruitment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DeprescriptionsPatient ParticipationClinical Trials as TopicHumansAgedMaleFemaleAustraliaUnited StatesSurveys and QuestionnairesAged, 80 and over

Stichwörter der Autor:innen

content analysisdeclinedeprescribepreferencessurvey

Autor:innen und Institutionen

  • Department of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, Michigan, USA.
  • University of Michigan Center for Bioethics and Social Sciences in Medicine, Ann Arbor, Michigan, USA.
  • University of Michigan School of Public Health, Ann Arbor, Michigan, USA.
  • Department of Internal Medicine, University of Michigan School of Medicine, Ann Arbor, Michigan, USA.
  • Sydney Health Literacy Lab, Sydney School of Public, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.
  • Leeder Centre for Health Policy, Economics, and Data, Sydney School of Public, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.

ORCID-Profile: Sarah E Vordenberg, Alexander Chaitoff, Kristie Rebecca Weir

Förderung

  • National Health and Medical Research Council
  • University of Michigan Center for Bioethics and Social Sciences in Medicine

Zitieren

APA

Vordenberg, S. E., Dulo, N., Chaitoff, A., Ingwersen, K., & Weir, K. R. (2026). Willingness to Participate in Deprescribing Trials: A Survey of Older Adults in Two Countries. Journal of the American Geriatrics Society. https://doi.org/10.1111/jgs.70186

Vancouver

Vordenberg SE, Dulo N, Chaitoff A, Ingwersen K, Weir KR. Willingness to Participate in Deprescribing Trials: A Survey of Older Adults in Two Countries. Journal of the American Geriatrics Society. 2026. doi:10.1111/jgs.70186

BibTeX
@article{Vordenberg2026,
  author = {Vordenberg, Sarah E and Dulo, Noelia and Chaitoff, Alexander and Ingwersen, Kirsten and Weir, Kristie Rebecca},
  title = {Willingness to Participate in Deprescribing Trials: A Survey of Older Adults in Two Countries},
  journal = {Journal of the American Geriatrics Society},
  year = {2026},
  doi = {10.1111/jgs.70186}
}
Kostenlos starten →